SEC Form 4 · accession 0001607062-18-000088
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Nov 13, 2017
Accepted (ET)
Mar 22, 2018 · 1:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 13, 2017 | S | 204,396 | $1.8276 | D | 817,584 | D | |
| Common StockF1,F2 | Nov 15, 2017 | S | 204,396 | $1.8276 | D | 613,188 | D | |
| Common StockF1,F2 | Nov 17, 2017 | S | 204,396 | $1.8276 | D | 408,792 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects 12 for 1 reversed stock split effective November 16, 2017.
- F2The shares were sold for approximate aggregate purchase price of $373,554.